While BB4 targets the CD138+ MM cells, ULBP2 stimulates the NKG2D receptor on NK cells and triggers the release of soluble factors involved in NK recruitment and activation of cytotoxicity. This evidence concerns the gene SDC1 and Miyoshi myopathy.